NCT02297828View on ClinicalTrials.gov

Effect of Boussignac CPAP Ventilation on PaO2 and PaO2/FiO2 Ratio in Morbidly Obese Patients Undergoing Bariatric Surgery

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Morbid Obesity
Interventions
DEVICE

Boussignac CPAP

Boussignac CPAP with a 50% FiO2 (adjusted in a piece adapted to the system) and a pressure of 5cmH2O (measured with a manometer) is applied immediately after extubation and mantained for two hours after extubation in the post anesthesia care unit (PACU).

DEVICE

Venturi face mask

Venturi mask with a 50% FiO2 is used immediately after extubation and mantained for two hours in the post anesthesia care unit (PACU).

Trial Locations (1)

4099-001

Centro Hospitalar Porto, Porto

All Listed Sponsors
lead

Centro Hospitalar do Porto

OTHER

NCT02297828 - Effect of Boussignac CPAP Ventilation on PaO2 and PaO2/FiO2 Ratio in Morbidly Obese Patients Undergoing Bariatric Surgery | Biotech Hunter | Biotech Hunter